<DOC>
	<DOCNO>NCT01496937</DOCNO>
	<brief_summary>The purpose exploratory first-in-human study evaluate amount GLPG0974 present blood ( pharmacokinetics ) single oral dos GLPG0974 give healthy subject . Furthermore , course study , safety tolerability well effect GLPG0974 mechanism action-related parameter blood ( pharmacodynamics ) characterize compare placebo .</brief_summary>
	<brief_title>First-in-Human Exploratory Single Ascending Dose GLPG0974</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Healthy male , age 1850 year BMI 1830 kg/m2 Any condition might interfere procedure test study Drug alcohol abuse Smoking</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>